/Investor DB

Section 32 — 2021 Investments

10 investments dated 2021 · listed companies and verified rows first · show all

ScienceIOscience.ioinOct 2021✓ verifiedAcquired

ScienceIO offers an AI platform for interpreting healthcare data, including a product that converts unstructured medical text into structured data via an API and maps it to millions of medical concepts.

AI & Machine LearningData & InfrastructureDigital HealthHealthtech

Will Manidis(Founder, CEO)Gaurav Kaushik(Founder, President)

Co-investorsEarl Grey CapitalSwell PartnersToba CapitalAlt CapitalLachy GroomQuiet Capital+12 more

Arbor Biotechnologiesarbor.bioin𝕏Nov 2021 · $215M

Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.

BiotechDigital HealthMedical DevicesCambridge, US

DAVID ARTHUR SCOTT(Executive Officer)inWINSTON XIA YAN(Executive Officer)FENG ZHANG(Director)Feng Zhang, Ph.D.(Arbor Co-founder and Scientific Advisory Board Chair)David Walt, Ph.D.(Arbor Co-founder)David Scott, Ph.D.(Arbor Co-founder)

Co-investorsARCH Venture PartnersGreatPoint VenturesIllumina VenturesOno Venture Investment, Inc.TCG CrossoverAlly Bridge Group+5 more

C2i Genomicsc2i-genomics.comin𝕏Apr 2021 · $100MAcquired

C2i Genomics develops a whole-genome sequencing platform that uses AI algorithms to build patient-specific cancer signatures for detecting minimal residual disease (MRD) and monitoring cancer.

AI & Machine LearningBiotechDigital HealthHealthtechNew York, US

Asaf Zviran(Founder)inEzra Sofer(Executive Officer, Director)

BoardEli Casdin(Director)inAlex Parker(Director)Shaun Rodriguez(Director)in

Co-investorsiGlobe PartnersLionBirdNat TurnerNFXCasdin Capital

Current Healthcurrenthealth.comin𝕏Apr 2021 · $43Macquired by Best Buy

Current Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings.

AI & Machine LearningDigital HealthHealthtechMedical DevicesEdinburgh, US

Christopher McGhee(Founder)in

Co-investorsLRVHealthMMC VenturesOSF VenturesPerot JainNorthpond Ventures

Dialpaddialpad.comin𝕏Dec 2021

Dialpad provides a platform that transforms customer conversations into actionable intelligence for businesses.

AI & Machine LearningEnterprise SoftwareFuture of WorkSaaSSan Ramon, US

Craig Walker(Founder)inJohn Rector(Founder)inBrian Peterson(Founder)inLily Toy(Executive Officer)inDan O'Connell(Founder)inVincent Paquet(Founder)

Co-investors1435 Capital3Spoke CapitalAcrew CapitalAndreessen HorowitzAtomicCerity Partners Ventures+19 more

EQRxeqrx.comJan 2021Acquired

EQRx was a Cambridge, MA biopharma that aimed to sell lower-priced novel drugs; it was acquired by Revolution Medicines in 2023.

Alexis Borisy(Founder)

Co-investorsAndreessen HorowitzArboretum VenturesARCH Venture PartnersGV (Google Ventures)Nextech InvestBain Capital+1 more

Gretelgretel.aiin𝕏Sep 2021 · $50MAcquired

Gretel provides synthetic data generation tools that enable developers to create high-quality, domain-specific datasets for training agentic AI systems and language models.

AI & Machine LearningData & InfrastructureDeveloper ToolsSaaSSan Diego, US

Ali Golshan(Founder)inLaszlo Bock(Founder)Alex Watson(Founder)John Myers(Founder)

BoardSridhar Ramaswamy(Board Partner (Greylock))inKelly Perdew(Director)in

Co-investorsEnzo VenturesExtension FundGreylock PartnersInsurtech Gateway FundMoonshots CapitalS32+3 more

MedArrivemedarrive.comNov 2021

MedArrive provides software for scheduling, routing, and real-time tracking of in-home care delivery teams.

HealthtechLogistics & Supply ChainSaaSNew York, US

Inna Plumb(Executive Officer)inDaniel Trigub(Executive Officer, Director)

BoardWilliam Sullivan(Director)Annie Case(Director)inAndy Harrison(Director)Agneta Breitenstein(Director)in

Co-investors7wire VenturesCobalt VenturesCorewell Health VenturesDeclaration PartnersKleiner PerkinsDefine Ventures+2 more

ROME Therapeuticsrometx.comSep 2021

Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.

Benjamin Greenbaum(Founder)David Ting(Founder)Rosana Kapeller(Founder)

Co-investorsAndreessen HorowitzARCH Venture PartnersGV (Google Ventures)Luma GroupSanofi VenturesAbingworth+11 more

Wise Systemswisesystems.comin𝕏Oct 2021 · $50M

Wise Systems provides an AI-driven routing optimization platform for delivery and fleet operations.

AI & Machine LearningData & InfrastructureLogistics & Supply ChainMobility & TransportationSaaSCambridge, US

Charles Sims II(Executive Officer, Director)Ali Kamil(Founder)inLayla Shaikley(Founder)inJemel Derbali(Founder)inChazz Sims(Founder)in

BoardDr. Sandy Pentland

Co-investorsBantam GroupFontinalis PartnersGradient VenturesGutbrain VenturesTechstarsThe E14 Fund+6 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.